AnBogen 在AACR上提出了Imofinostat的数据,显示它有助于免疫治疗抗击结直肠癌. AnBogen presents data on Imofinostat at AACR showing it helps immunotherapy fight colorectal cancer.

在2026年AACR会议上,AnBogen Therapeutics将在Imofinostat药物上的研究报告. AnBogen Therapeutics will present research on its drug Imofinostat at the 2026 AACR meeting. 数据显示它有助于免疫治疗结直肠癌, 并准胰腺癌的抗药性. The data show it helps immunotherapy fight colorectal cancer and targets resistance in pancreatic cancer. 这支持正在进行的临床试验,用于晚期结直肠癌三重治疗. This supports ongoing clinical trials for triple therapy in advanced colorectal cancer.